Project/Area Number |
22591166
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Pediatrics
|
Research Institution | Kyoto Prefectural University of Medicine |
Principal Investigator |
TSUCHIYA Kunihiko 京都府立医科大学, 大学院・医学研究科小児発達医学, 助教 (90381938)
|
Co-Investigator(Kenkyū-buntansha) |
HOSOI Hajime 京都府立医科大学, 大学院・医学研究科小児発達医学, 教授 (20238744)
IEHARA Tomoko 京都府立医科大学, 大学院・医学研究科小児発達医学, 講師 (20285266)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
Fiscal Year 2012: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
|
Keywords | 横紋筋肉腫 / 融合遺伝子 / LXXLL motif / 分子標的療法 / PAX3-NCOA2 / PAX3-FKHR |
Research Abstract |
We analyzed a complex chromosomal translocation in a case of embryonal rhabdomyosarcoma (RMS) and identified the translocation as one that generates the fusion gene PAX3-NCOA2. Because the role of this translocation in RMS tumorigenesis is unknown, we established two types of stable mouse myoblast C2C12 cell lines expressing PAX3-NCOA2 and PAX3-FKHR, respectively . Compared to control cells, PAX3-NCOA2 cells grew faster, were more motile, were less anchorage dependent and showed greater transcriptional activation of the PAX3 consensus binding site. These results indicate that the PAX3-NCOA2 fusion gene has a dual role in the tumorigenesis of RMS to prome the proliferation and to inhibit the myogenic differentiation.
|